IP Library Granted Patent US 12,221,633
Granted Patent B2
US 12,221,633 · App. 18/348,544 · Granted Feb 11, 2025

Modified reverse transcriptases

Inventors: Arkadiusz Bibillo (Walnut Creek, CA); Pranav Patel (Pleasanton, CA)
Assignee: BIO-RAD LABORATORIES, INC.
C12N9/1276C12Y207/07049C07K2319/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,221,633
App. No.
18/348,544
Granted
Feb 11, 2025
Kind
B2
Abstract

The present disclosure provides methods and systems for amplifying and analyzing nucleic acid samples. The present disclosure provides methods for preparing cDNA and/or DNA molecules and cDNA and/or DNA libraries using modified reverse transcriptases.

Claims (19)

1. A non-naturally occurring enzyme, comprising (i) a finger domain derived from an R2 retrotransposon; (ii) a thumb domain derived from an R2 retrotransposon; and (iii) an endonuclease domain derived from an R2 retrotransposon, and an amino acid sequence with at least 95% identity to SEQ ID NO: 20.

2. The non-naturally occurring enzyme of claim 1 , further comprising a palm domain derived from an R2 retrotransposon.

3. The non-naturally occurring enzyme of claim 1 , further comprising a fusion-tag molecule.

4. The non-naturally occurring enzyme of claim 3 , wherein the fusion-tag molecule stabilizes the non-naturally occurring enzyme.

5. The non-naturally occurring enzyme of claim 3 , wherein the fusion-tag molecule is selected from the group consisting of: Fh8, MBP, NusA, Trx, SUMO, GST, SET, GB1, ZZ, HaloTag, SNUT, Skp, T7PK, EspA, Mocr, Ecotin, CaBP, ArsC, IF2-domain I, an IF2-domain I derived tag, RpoA, SlyD, Tsf, RpoS, PotD, Crr, msyB, yjgD, rpoD, and His6.

6. The non-naturally occurring enzyme of claim 3 , wherein the fusion-tag molecule is selected from the group consisting of: His-tag, His6-tag, Calmodulin-tag, CBP, CYD (covalent yet dissociable NorpD peptide), Strep II, FLAG-tag, HA-tag, Myc-tag, S-tag, SBP-tag, Softag-1, Softag-3, V5-tag, Xpress-tag, Isopeptag, SpyTag, B, HPC (heavy chain of protein C) peptide tags, GST, MBP, biotin, biotin carboxyl carrier protein, glutathione-S-transferase-tag, green fluorescent protein-tag, maltose binding protein-tag, Nus-tag, Strep-tag, and thioredoxin-tag.

7. The non-naturally occurring enzyme of claim 1 , wherein at least one of the finger domain, the thumb domain, or the endonuclease domain is derived from an arthropod.

8. The non-naturally occurring enzyme of claim 1 , wherein at least one of the finger domain, the thumb domain, or the endonuclease domain is derived from a silkmoth.

9. The non-naturally occurring enzyme of claim 1 , wherein at least one of the finger domain, the thumb domain, or the endonuclease domain is derived from a vertebrate or an echinoderm.

10. The non-naturally occurring enzyme of claim 1 , wherein at least one of the finger domain, the thumb domain, or the endonuclease domain is derived from a flatworm or a hydra.

11. The non-naturally occurring enzyme of claim 1 , wherein the enzyme comprises a mutagenized motif-1 sequence.

12. The non-naturally occurring enzyme of claim 11 , wherein the mutagenized motif-1 sequence has an improved jumping activity as compared to a wild-type sequence.

13. The non-naturally occurring enzyme of claim 1 , wherein the enzyme comprises a mutagenized motif 0 sequence.

14. The non-naturally occurring enzyme of claim 13 , wherein the mutagenized motif 0 sequence has an improved jumping activity as compared to a wild-type sequence.

15. The non-naturally occurring enzyme of claim 1 , wherein the enzyme comprises a mutagenized thumb sequence.

16. The non-naturally occurring enzyme of claim 15 , wherein the mutagenized thumb sequence has an improved single-stranded priming efficiency.

17. The non-naturally occurring enzyme of claim 15 , wherein the mutagenized thumb sequence has an improved processivity.

18. The non-naturally occurring enzyme of claim 1 , wherein the enzyme has a processivity of 20 nucleotides or longer.

19. The non-naturally occurring enzyme of claim 1 , wherein the enzyme comprises SEQ ID NO: 20.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2023
From: BIBILLO, ARKADIUSZ; PATEL, PRANAV
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 065132/0445 →
Continuity (4)
Continuation 17055801
Provisional Application 62779371 · Dec 13, 2018
Provisional Application 62672480 · May 16, 2018
Related Publication 20240026316A1 · Jan 25, 2024
References Cited (9)
US 11739307B2 · Bibillo · 2023 [cited by examiner]
US 20060281079A1 · Eickbush · 2006 [cited by examiner]
US 20140363854A1 · Smith · 2014 [cited by examiner]
Accession A0A0V0TAN8. Mar. 16, 2016. (Year: 2016). [cited by examiner]
Accession A0A0V0T7M5. Mar. 16, 2016 (Year: 2016). [cited by applicant]
Chica et al. Curr Opin Biotechnol. Aug. 2005; 16(4):378-84. (Year: 2005). [cited by applicant]
Singh et al. Curr Protein Pept Sci. 2017, 18, 1-11 (Year: 2017). [cited by applicant]
Thompson et al. Mob Genet Elements. May-Jun. 2011; 1 (1): 29-37 (Year: 2011). [cited by applicant]
Jamburuthugoda et al. Nucleic Acids Res. Jul. 2014;42(13):8405-15.Epub Jun. 23, 2014 (Year: 2014). [cited by applicant]